UCSF HELEN DILLER FAMILY COMPREHENSIVE CANCER CENTER

Presentations
Predicting overall survival (OS) and progression-free (PFS) for oropharynx
cancers (OPC) in NRG Oncology RTOG0129/0522 with nomograms.
Authors*: Carole Fakhry, Qiang Zhang, Maura L. Gillison, Phuc Duy Nguyen, David Ira Rosenthal,
Randal S. Weber, Louise Lambert, Andy Trotti, William Barrett, Wade Thorstad, Sue S Yom, Stuart J. Wong,
John A. Ridge, Shyam S. Rao, James A. Bonner, Eric Vigneault, David Raben, Jonathan Harris, Quynh-Thu Le
Abstract #: 6024
Presentation Date/Time: Saturday, June 4: 1:00 - 4:30 PM
Location: Hall A, Poster Board #346
Session: Head and Neck Cancer
Citation: J Clin Oncol 34, 2016 (suppl; abstr 6024)
Yom Research Interests: Dr. Yom is an expert in head and neck, thoracic, and skin cancers and conducts
research in quality of life and supportive care, patient-oriented decision making, and combinations of novel
targeted therapies and immunotherapy with radiation therapy. She is the principal investigator of HN002,
a national trial in de-intensified therapy for HPV+ oropharyngeal cancer. She serves on several national
panels developing guidelines for appropriate care of head and neck cancers.
http://profiles.ucsf.edu/sue.yom
__________________________________________________________________________
The prognostic role of gender, race and human papillomavirus (HPV)
in oropharyngeal squamous cell cancer (OPC) and non-oropharyngeal
head and neck squamous cell cancer (non-OP HNC).
Authors*: Carole Fakhry, William H. Westra, Steven Wang, Annemieke VanZante, Yuehan Zhang,
Eleni Marie Rettig, Alicia Wentz, Young Jun Kim, Justin A. Bishop, Wayne Koch, Christine Gail Gourin,
Jeremy Richmon, David Eisele, Gypsyamber D’Souza
Abstract #: 6068
Presentation Date/Time: Saturday, June 4: 1:00 - 4:30 PM
Location: Hall A, Poster Board #390
Session: Head and Neck Cancer
Citation: J Clin Oncol 34, 2016 (suppl; abstr 6068)
*UCSF authors in bold
28